Trial · NCT01453049
Outcomes33
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
21 to 33 of 33
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| SECONDARY | Change From Baseline in Red Blood Cell (RBC) Count at Week 24/EW | Baseline (Week 0) and Week 24/EW | Safety Population. Only those participants contributing data at the indicated time points were analyzed. | Pico per liter (10^12/ L) cells | MEAN |
| SECONDARY | Change From Baseline in Lymphocytes, Monocytes, Neutrophils, Eosinophils, and Basophils at Week 24/EW | Baseline (Week 0) and Week 24/EW | Safety Population. Only those participants contributing data at the indicated time points were analyzed. | percent of WBC count | MEAN |
| SECONDARY | Change From Baseline in Hematocrit (HCT) at Week 24/EW | Baseline (Week 0) and Week 24/EW | Safety Population. Only those participants contributing data at the indicated time points were analyzed. | percentage of volume of whole blood | MEAN |
| SECONDARY | Change From Baseline in Hemoglobin (HE), Mean Corpuscular Hemoglobin Concentration (MCHC), Total Protein (TP), and Albumin at Week 24/EW | Baseline (Week 0) and Week 24/EW | Safety Population. Only those participants contributing data at the indicated time points were analyzed. | Grams per liter (G/L) | MEAN |
| SECONDARY | Change From Baseline in Mean Corpuscular Volume (MCV) at Week 24/EW | Baseline (Week 0) and Week 24/EW | Safety Population. Only those participants contributing data at the indicated time points were analyzed. | Femtoliters (FL) per cell | MEAN |
| SECONDARY | Change From Baseline in Mean Corpuscular Hemoglobin (MCH) at Week 24/EW | Baseline (Week 0) and Week 24/EW | Safety Population. Only those participants contributing data at the indicated time points were analyzed. | Picograms (pg) per cell | MEAN |
| SECONDARY | Change From Baseline in Alanine Transaminase (ALT), Aspartate Aminotransferase (AST), Gamma-glutamyl Transpeptidase (GGT), Lactate Dehydrogenase (LDH), Alkaline Phosphatase (ALP), and Creatine Kinase (CK) at Week 24/EW | Baseline (Week 0) and Week 24/EW | Safety Population. Only those participants contributing data at the indicated time points were analyzed. | Units per liter (U/L) | MEAN |
| SECONDARY | Change From Baseline in Total Bilirubin (TB), Direct Bilirubin (DB), Creatinine, and Uric Acid (UC) at Week 24/EW | Baseline (Week 0) and Week 24/EW | Safety Population. Only those participants contributing data at the indicated time points were analyzed. | Micromoles per liter (mcmol/L) | MEAN |
| SECONDARY | Change From Baseline in Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) at Week 24/EW | Baseline (Week 0) and Week 24/EW | Safety Population. Only those participants contributing data at the indicated time points were analyzed. | Millimeters of mercury (mmHg) | MEAN |
| SECONDARY | Change From Baseline in Heart Rate at Week 24/EW | Baseline (Week 0) and Week 24/EW | Safety Population. Only those participants contributing data at the indicated time points were analyzed. | beats per minute (bpm) | MEAN |
| SECONDARY | Change From Baseline in Weight at Week 24/EW | Baseline (Week 0) and Week 24/EW | Safety Population. Only those participants contributing data at the indicated time points were analyzed. | kilograms (kg) | MEAN |
| SECONDARY | Change From Baseline in Electrocardiogram (ECG) Assessment of Heart Rate at Week 24/EW | Baseline (Week 0) and Week 24/EW | Safety Population. Only those participants contributing data at the indicated time points were analyzed. | bpm | MEAN |
| SECONDARY | Change From Baseline in Electrocardiogram (ECG) Data at Week 24/EW | Baseline (Week 0) and Week 24/EW | Safety Population. Only those participants contributing data at the indicated time points were analyzed. | milliseconds (msec) | MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01453049/outcomes?page=2